PET/CT Staging of Rectal Carcinoma
This article focuses on the impact of 18F-FDG PET/CT on the management of rectal cancer. The current use of PET/CT in the diagnosis, initial staging, and detection of recurrence of the disease is discussed in the light of recent available data. Furthermore, this article presents the evolving role of PET/CT in radiation therapy planning and in the assessment of response to neoadjuvant chemotherapy and to locoregional treatment of liver metastases.
Keywords18F-FDG PET/CT Rectal cancer Staging Recurrence Therapy monitoring Radiotherapy planning
- 3.N.C.C Network (2015) NCCN clinical practice guidelines in oncology: rectal cancer, version 1. 2016. J Natl Compr Cancer NetwGoogle Scholar
- 7.O’Connor OJ, McDermott S, Slattery J et al (2011) The use of PET-CT in the assessment of patients with colorectal carcinoma. Int J Surg Oncol 2011:14 Article ID 846512Google Scholar
- 14.Mosley CK, Schuster DM (2007) Practical PET/CT of the abdomen. In: Wani RL (ed) RSNA categorical course in diagnostic radiology—clinical PET and PET/CT imaging. RSNA, Chicago, pp 71–81Google Scholar
- 18.Koo PJ, Kim SJ, Chang S, Kwak JJ (2016) Interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomograopy to predict pathologic response to preoperative chemoradiotherapy and prognosis in patients with locally advanced rectal cancer. Clin Colorectal Cancer 15(4):e213–e219CrossRefGoogle Scholar
- 20.Gascini GL, Avallone A, Delrio P et al (2006) 18F FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241–1248Google Scholar